(MENAFN- EIN Presswire)
Emergen Research Logo
Premenstrual Syndrome (PMS) and Menstrual health Supplements market is expected to experience significant growth
VANCOUVER, BRITISH COLUMBIA, CANADA, January 21, 2025 /EINPresswire / -- The global Premenstrual Syndrome (PMS) and Menstrual Health Supplements market is expected to experience significant growth, increasing from an estimated $24.51 billion in 2024 to $42.12 billion by 2033, at a compound annual growth rate (CAGR) of 6.20%. This growth is being driven by increasing awareness of women's health, advancements in supplement formulations, and rising income levels in developed countries.
PMS, a condition characterized by physical and emotional symptoms during the luteal phase of the menstrual cycle, affects many women worldwide. Studies reveal that 20% of women experience severe symptoms that interfere with daily life, while 80% report mild to moderate discomfort. This has led to a growing demand for effective supplements that address these symptoms.
Download Free Sample PDF Copy Of This Report@
Key Drivers of Market Growth
Increased Awareness of Women's Health Needs
Rising consumer awareness about hormone balance and menstrual health has fueled demand for supplements. Deficiencies in essential vitamins and minerals such as B vitamins, Vitamin D, magnesium, and calcium have been linked to hormonal imbalances. Research by the National Institutes of Health (NIH) highlights the importance of these nutrients in managing PMS symptoms, driving the popularity of dietary supplements.
Government and private initiatives, such as India's Reproductive and Child Health Programme and other local campaigns, have further emphasized the importance of accessible menstrual health products. These efforts aim to educate women, particularly in rural areas, about the importance of sanitary pads and menstrual care.
Lifestyle Factors and Natural Solutions
Lifestyle choices also play a critical role in managing PMS symptoms. Research, including studies from Egypt, has linked PMS severity to dietary habits, such as high sugar consumption. This has encouraged women to seek natural, nutrient-based solutions, enhancing the appeal of menstrual health supplements.
Challenges in the Market
Regulatory Hurdles
While supplements for PMS are widely regarded as nutrition products, regulatory standards vary significantly across regions. For instance, in the United States, supplements fall under the Dietary Supplement Health and Education Act (DSHEA), which mandates safety but allows more flexibility compared to pharmaceuticals. In contrast, stricter regulations in the European Union require substantial scientific evidence for product claims, limiting marketing potential.
Market Segmentation Insights
Dominance of Combined Nutritional Supplements
In 2024, combined nutritional supplements are expected to account for the majority of market revenue. These products combine complementary nutrients, such as magnesium with vitamin D3, or omega-3 fatty acids with vitamin E, offering convenience and improved effectiveness. This combination approach is favored by consumers seeking simplified solutions for symptom relief.
Growth of Single Nutritional Supplements
Single nutritional supplements are also gaining traction and are projected to grow significantly. Their reliability makes them a preferred choice for healthcare providers recommending tailored nutritional interventions. Vitamins, in particular, are key for managing both physical and emotional PMS symptoms, reinforcing their importance in this segment.
Regional Insights
In developed regions, such as North America and Europe, rising income levels and enhanced health awareness are driving market growth. Meanwhile, initiatives in emerging markets, such as India, are playing a pivotal role in increasing accessibility to menstrual health products.
Request For Customization:
The competitive landscape of the report has been formulated by considering all the vital parameters such as company profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial standing, market position, and expansion plans. The report also discusses in detail the recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among others. The report also sheds light on the recent technological developments and product advancements in the Premenstrual Syndrome and Menstrual Health Supplements market.
Furthermore, the report provides details about the new players entering the market, entry-level barriers and offers strategic recommendations to overcome those barriers to gain a substantial industry presence.
Some of the key companies in the global Premenstrual Syndrome and Menstrual Health Supplements Market include
Herbalife International of America, Inc.
Pharmavite LLC
Nature's Bounty
Amway
GNC Holdings, Inc.
USANA Health Sciences, Inc.
GlaxoSmithKline Plc
MetP Pharma AG
RBK Nutraceuticals Pty Ltd.
Archer Daniels Midland
Power Gummies
Looni
DM Pharma
The global Premenstrual Syndrome and Menstrual Health Supplements market report covers the analysis of drivers, trends, limitations, restraints, and challenges arising in the Premenstrual Syndrome and Menstrual Health Supplements market. The report also discusses the impact of various other market factors affecting the growth of the market across various segments and regions. The report segments the market on the basis of types, applications, and regions to impart a better understanding of the Premenstrual Syndrome and Menstrual Health Supplements market.
Premenstrual Syndrome and Menstrual Health Supplements Market Segmentation Analysis
By Product Outlook (Revenue, USD Million; 2020-2033)
Single Nutritional Supplements
Vitamins
Minerals
Herbal Supplements
Others
Combined Nutritional Supplements
By Consumer Outlook (Revenue, USD Million; 2020-2033)
Premenstrual Syndrome (PMS)
Perimenopause
By Formulation Outlook (Revenue, USD Million; 2020-2033)
Capsules/Tablets
Powder
Softgels
Others
By Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Quick Buy-
The Global Premenstrual Syndrome and Menstrual Health Supplements Market is further analyzed across the key geographical locations where the market has expanded to a significant size. The key region analyzed are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report offers a country-wise analysis to provide a comprehensive analysis of the Premenstrual Syndrome and Menstrual Health Supplements market in terms of production and consumption patterns, supply and demand ratio, import/export, revenue contribution, trends, and presence of prominent players in each region.
The Premenstrual Syndrome and Menstrual Health Supplements market is poised for steady growth as consumer awareness and demand for natural, science-backed solutions continue to rise. With increasing regulatory support and product innovation, the market is expected to offer effective and accessible solutions to millions of women worldwide.
Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN20012025003118003196ID1109109672